GLP-1 Market
LLY $1240.34 ▼ -1.3% NVO $38.42 ▼ -1.1% PFE $29.44 ▼ -0.5% VKTX $25.05 ▼ -0.5% KLRA $11.43 ▲ +1.6% GPCR $22.01 ▲ +4.4% RHHBY $57.14 • 0.0%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Allogeneic pancreatic endocrine cell clusters

Company
Seraxis
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
None currently listed

Efficacy results: Not yet reported

No recruiting studies currently listed

See all studies for this drug

Data source: ClinicalTrials.gov · trial data as of Oct 20, 2026

Trial details
  • Withdrawn NCT NCT06651515

    A Study of the Safety and Efficacy of Pancreatic Endocrine Cell Clusters Implanted Into the Omentum of Type 1 Diabetes Patients With Severe Hypoglycemia

    Not yet reported, Not yet reported Seraxis Est. completion 2028-03 2 sites Stand-alone
    Other conditions: Diabetes Mellitus Type 1
    View official trial listing →
  • Not yet recruiting NCT NCT07581197

    Study of the Safety and Efficacy of Pancreatic Endocrine Cells in Adult Patients With Type 1 Diabetes

    Not yet reported, Not yet reported Seraxis 9 participants Est. completion 2029-11 Stand-alone
    Other conditions: Diabete Mellitus, Diabete Type 1
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.